Experiment: 6BQI

SOLUTION NMR - SOLUTION SCATTERING

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCA	1 mM [U-13C; U-15N] Yih1 (Yeast Impact Homologue)	95% H2O/5% D2O	30 mM	7.2	1 atm	298	Bruker AVANCE 700
2	3D HNCACB	1 mM [U-13C; U-15N] Yih1 (Yeast Impact Homologue)	95% H2O/5% D2O	30 mM	7.2	1 atm	298	Bruker AVANCE 700
3	3D 1H-15N NOESY	1 mM [U-13C; U-15N] Yih1 (Yeast Impact Homologue)	95% H2O/5% D2O	30 mM	7.2	1 atm	298	Bruker AVANCE 700
4	3D H(CCO)NH	1 mM [U-13C; U-15N] Yih1 (Yeast Impact Homologue)	95% H2O/5% D2O	30 mM	7.2	1 atm	298	Bruker AVANCE 700
5	3D HCCH-TOCSY	1 mM [U-13C; U-15N] Yih1 (Yeast Impact Homologue)	95% H2O/5% D2O	30 mM	7.2	1 atm	298	Bruker AVANCE 700
6	3D 1H-13C NOESY aliphatic	1 mM [U-13C; U-15N] Yih1 (Yeast Impact Homologue)	95% H2O/5% D2O	30 mM	7.2	1 atm	298	Bruker AVANCE 700
7	2D 1H-15N HSQC	1 mM [U-13C; U-15N] Yih1 (Yeast Impact Homologue)	95% H2O/5% D2O	30 mM	7.2	1 atm	298	Bruker AVANCE 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	700

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	250
Conformers Submitted Total Number	10
Representative Model	1 (closest to the average)

Additional NMR Experimental Information
Details	The authors state that cluster 2 (as in validation report, 3 structures) is consistent with sPRE and Mass spectrometry data.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
2	chemical shift assignment	CARA		Keller and Wuthrich
3	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
4	peak picking	ATNOS		Hermann

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.